LONDON (Reuters UK) - Oxford BioMedica OXB said a final stage clinical trial of its biggest drug hope, TroVax, in renal cancer did not meet its main goal, sending shares plunging as much as three-quarters in value. The independent Data Safety Monitoring Board advised the ...
Steve Farrington submits: There are nearly 133 million Americans alone considered overweight- putting them at risk for the rapidly growing Type II Diabetes. I have done a bit of research on projections as to how many Americans would be living with the disease in the future. And I have...
Mike Huckman submits: Tree huggers (just a colloquialism, not a dig) will be glad to know that biopharmaceutical companies submit their Food and Drug Administration filings for drug approval electronically these days. Dr. Tony Ware, the head of Eli Lilly's LLY cardiovascular unit, says his people tell him that...
Mike Huckman submits: Last week, Pfizer PFE made a major announcement regarding the world's top-selling statin, Lipitor. Pfizer struck a deal with the Indian generic drugmaker Ranbaxy to ward off the threat of generic competition for Lipitor until late 2011. I know there were a lot of market pressures...
Eben Tessari submits: Image via Wikipedia Sanofi-Aventis SNY plans to make a $2.57 billion (10% premium) offer for Czech generic drugmaker Zentiva, trumping a bid from financial group PPF. Sanofi’s move on Zentiva follows Daiichi Sankyo’s $4.6B offer for India’s top generic company, Ranbaxy. by Eben Tessari
R.J Steffens submits: The American Diabetes Association's 68th Scientific Sessions kicked off in San Francisco on June 6th and ends June 10th. Large pharma dominates the exhibition and use the venue to present their latest study results in an effort to orientate health care professionals on the products they may...
Paul Price submits: Sanofi?Aventis SNY is the 4th largest drug company in the world and a big holding of Berkshire Hathaway (BRK.A) (BRK.B). They've earned an 'A+' financial strength rating and an 85th percentile 'stock price stability' grade from Value Line. 2008 sales, earnings, cash...
KNOXVILLE, Tenn. -- Chris Bevil has been named vice president of sales for Varsity Sports Media VSM. Bevil will be based in Knoxville, where he will be responsible for all sales management duties for VSM, and will work closely with Craig Baroncelli, VSM general manager and publisher, on marketing strategies...
Report in Good Clinical Practice Journal GCPj Finds That Novartis Leads the Pack for Ongoing Trials in Autoimmune, Cardiovascular, and Metabolic Diseases Sanofi-aventis Takes the Top Rank for Ongoing Oncology Trials NEW YORK, June 30 /PRNewswire/ -- In a new Expert Analysis article published in...
- New combination vaccine offers good fit to childhood immunization schedule providing protection with fewer shots - SWIFTWATER, Pa., June 26 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that its PentacelR, Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and...
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/1d8ee0/competitor_analysi) has announced the addition of the "Competitor Analysis: Antihypertensives" report to their offering. The Competitive Intelligence Report Antihypertensives as of June 2008 provides a competitor analysis in the development pipeline of novel treatments of pulmonary artery hypertension, arterial hypertension, portal hypertension...
NEW BRUNSWICK, N.J., June 24 /PRNewswire/ -- NJ Department of Community Affairs is pleased to announce that sanofi-aventis allocates $1,000,000 to the Neighborhood Revitalization Tax Credit Program, NJ Department of Community Affairs. This is the largest contribution committed to one nonprofit organization since the inception of the New Jersey...
- PentacelR vaccine is the first 5-in-1 pediatric combination for immunization against diphtheria, tetanus, pertussis, polio and Haemophilus influenzae type b Hib - SWIFTWATER, Pa. and LYON, France, June 23 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food...
PRAGUE AFP — Czech-based generic drugs giant Zentiva was at the heart of a takeover tussle Wednesday after French group Sanofi-Aventis struck back with an offer countering a bid by local financial concern PPF. PPF, holding a 19.2 percent stake in Zentiva, which has substantial markets in Slovakia,...
NEW YORK, June 17 /PRNewswire/ -- Among US primary care physicians, Novartis earns the highest sales rep relationship scores, followed by Pfizer, Merck, GlaxoSmithKline and Sanofi-Aventis, according to new research from TNS Healthcare. Novartis also takes the top spot in Europe, demonstrating a consistent ability to build strong...
PITTSBURGH, June 16 /PRNewswire-FirstCall/ -- Mylan Inc. today announced that its subsidiary, Mylan Pharmaceuticals Inc., has received tentative approval from the U.S. Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for Irbesartan and Hydrochlorothiazide Tablets, 150 mg/12.5 mg and 300 mg/12.5 mg. ...
Worldwide COGENT-1 Study of CGT-2168 Expands to Europe; Focus on Reducing Gastrointestinal Side Effects of Antiplatelet Therapy MENLO PARK, Calif., June 16 /PRNewswire/ -- Cogentus Pharmaceuticals, Inc. today announced that the first patient has been enrolled in Europe in the company's pivotal Phase 3 study of its...
LYON, France and SWIFTWATER, Pa., June 16 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today its commitment to donate 60 million doses of H5N1 vaccine to the World Health Organization WHO over 3 years for the establishment of an H5N1 vaccine global stockpile. ...
Ambien CRR 12.5 mg significantly improved sleep onset, sleep maintenance and total sleep time compared to placebo BRIDGEWATER, N.J., June 10 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today results from a new study that showed Ambien CRR (zolpidem tartrate extended-release) CIV tablets 12.5 mg provided significant improvement in sleep...
PARIS AFP — French pharmaceutical company Sanofi-Aventis said on Monday it planned to cut about a third of its sales representatives in France, or 700-800 jobs. Management "confirms the existence of overstaffing for sales representatives which is estimated at 700-800 jobs," a spokeswoman told AFP, after a report...
